2Indicaciones aprobadas y perfil del candidato ideal Tirzepatida est aprobado en Espaa para dos indicaciones, que en la prctica con frecuencia se solapan en el mismo paciente: Control del peso en obesidad o sobrepeso: adultos con IMC mayor o igual a 30 kg/m, o mayor o igual a 27 kg/m con al menos una complicacin relacionada con el peso (HTA, dislipemia, DM2, ICFEp, apnea del sueo, entre otras)
Instead, he worked with several health advisors, including a medical team, a chef, and a sports nutritionist
The medication itself doesnt cause people to lose fluids, but similar to the way that GLP-1s quiet the bodys hunger signals, they can also dampen thirst signals, he explains
When in doubt, do not use the product
With consistent guidance from our licensed providers, youll stay supported throughout every stage of your weight loss journey for safe, sustainable results